The current study therefore aimed to describe the molecular spectrum of FH in Malaysian subjects (by screening the most likely affected exons), and to identify and correlate the LDLR gene mutations with the clinical manifestations of FH. The gene discussed is LDLR; the disease is familial hyperaldosteronism.